Literature DB >> 29526677

Epithelial Paradox: Clinical Significance of Coexpression of E-cadherin and Vimentin With Regard to Invasion and Metastasis of Breast Cancer.

Nami Yamashita1, Eriko Tokunaga2, Makoto Iimori3, Yuka Inoue4, Kimihiro Tanaka4, Hiroyuki Kitao3, Hiroshi Saeki4, Eiji Oki4, Yoshihiko Maehara4.   

Abstract

BACKGROUND: E-cadherin and vimentin are regarded as major conventional canonical markers of the epithelial-mesenchymal transition. It is commonly assumed that E-cadherin is uniformly lost during the process of epithelial-mesenchymal transition. Breast tumor cells typically invade as a cohesive multicellular unit in a process called collective invasion. The aim of this study was to reveal the clinical importance of the expression pattern of E-cadherin and vimentin in breast cancer.
METHODS: E-cadherin and vimentin protein expression was evaluated by immunohistochemistry in 176 invasive breast cancer samples. Among these, E-cadherin and vimentin expression were evaluated in the set of primary site and metastatic lymph nodes in 65 cases. In addition, E-cadherin and vimentin expression were analyzed by confocal laser scanning microscopy to see E-cadherin and vimentin localization in the breast cancer cells.
RESULTS: Both at the primary site and metastatic lymph nodes, both E-cadherin- and vimentin-positive tumors had the worst disease-free and overall survival among all cases. In addition, E-cadherin and vimentin protein is colocalized within the same tumor cells in a human breast cancer specimen.
CONCLUSION: Our present data suggest the existence of an aggressive subpopulation in the primary tumor nest of breast cancer.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aggressive; Collective invasion; EMT; Metastatic lymph nodes; Partial EMT

Mesh:

Substances:

Year:  2018        PMID: 29526677     DOI: 10.1016/j.clbc.2018.02.002

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN: 1526-8209            Impact factor:   3.225


  28 in total

1.  microRNA-877 contributes to decreased non-small cell lung cancer cell growth via the PI3K/AKT pathway by targeting tartrate resistant acid phosphatase 5 activity.

Authors:  Xue Bai; Changjun He; Bicheng Fu; Xianglong Kong; Jianlong Bu; Kaibin Zhu; Wei Zheng; Fucheng Zhou; Boxiong Ni
Journal:  Cell Cycle       Date:  2020-11-23       Impact factor: 4.534

2.  A systematic characterization of microglia-like cell occurrence during retinal organoid differentiation.

Authors:  Katarina Bartalska; Verena Hübschmann; Medina Korkut-Demirbaş; Ryan John A Cubero; Alessandro Venturino; Karl Rössler; Thomas Czech; Sandra Siegert
Journal:  iScience       Date:  2022-06-11

3.  MiR-137-3p Inhibits Colorectal Cancer Cell Migration by Regulating a KDM1A-Dependent Epithelial-Mesenchymal Transition.

Authors:  Xiaoling Ding; Jie Zhang; Ziqin Feng; Qianru Tang; Xiaorong Zhou
Journal:  Dig Dis Sci       Date:  2020-08-04       Impact factor: 3.199

4.  Polyploid giant cancer cells, stemness and epithelial-mesenchymal plasticity elicited by human cytomegalovirus.

Authors:  Zeina Nehme; Sébastien Pasquereau; Sandy Haidar Ahmad; Alain Coaquette; Chloé Molimard; Franck Monnien; Marie-Paule Algros; Olivier Adotevi; Mona Diab Assaf; Jean-Paul Feugeas; Georges Herbein
Journal:  Oncogene       Date:  2021-03-25       Impact factor: 9.867

5.  A Novel Approach for Quantifying Cancer Cells Showing Hybrid Epithelial/Mesenchymal States in Large Series of Tissue Samples: Towards a New Prognostic Marker.

Authors:  Louis Godin; Cédric Balsat; Yves-Rémi Van Eycke; Justine Allard; Claire Royer; Myriam Remmelink; Ievgenia Pastushenko; Nicky D'Haene; Cédric Blanpain; Isabelle Salmon; Sandrine Rorive; Christine Decaestecker
Journal:  Cancers (Basel)       Date:  2020-04-08       Impact factor: 6.639

6.  Berberine Attenuated Proliferation, Invasion and Migration by Targeting the AMPK/HNF4α/WNT5A Pathway in Gastric Carcinoma.

Authors:  Qian Hu; Lingli Li; Xin Zou; Lijun Xu; Ping Yi
Journal:  Front Pharmacol       Date:  2018-10-19       Impact factor: 5.810

7.  The evolution of surgical treatment for gastrointestinal cancers.

Authors:  Yoshihiko Maehara; Yuji Soejima; Tomoharu Yoshizumi; Naoyuki Kawahara; Eiji Oki; Hiroshi Saeki; Tomohiko Akahoshi; Toru Ikegami; Yo-Ichi Yamashita; Tadashi Furuyama; Keishi Sugimachi; Noboru Harada; Tetsuzo Tagawa; Norifumi Harimoto; Shinji Itoh; Hideto Sonoda; Koji Ando; Yuichiro Nakashima; Yoshihiro Nagao; Nami Yamashita; Yuta Kasagi; Takafumi Yukaya; Takeshi Kurihara; Ryosuke Tsutsumi; Shinkichi Takamori; Shun Sasaki; Tetsuo Ikeda; Yoshikazu Yonemitsu; Takasuke Fukuhara; Hiroyuki Kitao; Makoto Iimori; Yuki Kataoka; Takeshi Wakasa; Masami Suzuki; Koji Teraishi; Yasuto Yoshida; Masaki Mori
Journal:  Int J Clin Oncol       Date:  2019-09-14       Impact factor: 3.402

8.  E-Cadherin expression in human tumors: a tissue microarray study on 10,851 tumors.

Authors:  Eike Burandt; Felix Lübbersmeyer; Natalia Gorbokon; Franziska Büscheck; Andreas M Luebke; Anne Menz; Martina Kluth; Claudia Hube-Magg; Andrea Hinsch; Doris Höflmayer; Sören Weidemann; Christoph Fraune; Katharina Möller; Frank Jacobsen; Patrick Lebok; Till Sebastian Clauditz; Guido Sauter; Ronald Simon; Ria Uhlig; Waldemar Wilczak; Stefan Steurer; Sarah Minner; Rainer Krech; David Dum; Till Krech; Andreas Holger Marx; Christian Bernreuther
Journal:  Biomark Res       Date:  2021-06-05

Review 9.  Epithelial-to-Mesenchymal Transition in the Light of Plasticity and Hybrid E/M States.

Authors:  Laura Bornes; Guillaume Belthier; Jacco van Rheenen
Journal:  J Clin Med       Date:  2021-05-29       Impact factor: 4.241

10.  High-throughput microfluidic 3D biomimetic model enabling quantitative description of the human breast tumor microenvironment.

Authors:  Ilana Berger Fridman; James Kostas; Michal Gregus; Somak Ray; Matthew R Sullivan; Alexander R Ivanov; Smadar Cohen; Tania Konry
Journal:  Acta Biomater       Date:  2021-06-18       Impact factor: 10.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.